| actin filament based movement | GO:0030048 | 23 | 0.905 | |
| striated muscle contraction | GO:0006941 | 45 | 0.877 | |
| muscle system process | GO:0003012 | 141 | 0.862 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.857 | |
| transmembrane transport | GO:0055085 | 412 | 0.841 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.822 | |
| regulation of cardiac muscle contraction by calcium ion signaling | GO:0010882 | 9 | 0.790 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.773 | |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0014808 | 12 | 0.769 | |
| muscle contraction | GO:0006936 | 101 | 0.768 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.754 | |
| endoplasmic reticulum to cytosol transport | GO:1903513 | 12 | 0.750 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.708 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.708 | |
| blood circulation | GO:0008015 | 195 | 0.668 | |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0010880 | 10 | 0.661 | |
| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.657 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.628 | |
| calcium ion transport from endoplasmic reticulum to cytosol | GO:1903514 | 12 | 0.623 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.608 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.607 | |
| muscle cell development | GO:0055001 | 133 | 0.605 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.570 | |
| regulation of atp catabolic process | GO:1903289 | 9 | 0.548 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.537 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.493 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.488 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.467 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.459 | |
| cation transport | GO:0006812 | 399 | 0.451 | |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.444 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.427 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.418 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.415 | |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | GO:0010881 | 7 | 0.409 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.407 | |
| heart contraction | GO:0060047 | 93 | 0.398 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.382 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.370 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.368 | |
| regulation of atp metabolic process | GO:1903578 | 17 | 0.359 | |
| organelle assembly | GO:0070925 | 177 | 0.357 | |
| muscle fiber development | GO:0048747 | 76 | 0.356 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.333 | |
| muscle adaptation | GO:0043500 | 39 | 0.322 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.320 | |
| sarcomere organization | GO:0045214 | 24 | 0.316 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.306 | |
| myosin filament organization | GO:0031033 | 3 | 0.305 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.302 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.293 | |
| striated muscle cell development | GO:0055002 | 125 | 0.292 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.290 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.280 | |
| atp catabolic process | GO:0006200 | 55 | 0.279 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.273 | |
| sa node cell action potential | GO:0086015 | 4 | 0.272 | |
| positive regulation of atpase activity | GO:0032781 | 3 | 0.262 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.256 | |
| muscle tissue development | GO:0060537 | 308 | 0.250 | |
| myotube cell development | GO:0014904 | 60 | 0.244 | |
| heart morphogenesis | GO:0003007 | 178 | 0.244 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.241 | |
| circulatory system process | GO:0003013 | 197 | 0.240 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.237 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.237 | |
| atp metabolic process | GO:0046034 | 75 | 0.233 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.233 | |
| response to calcium ion | GO:0051592 | 20 | 0.232 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.229 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.227 | |
| calcium ion transport | GO:0006816 | 159 | 0.224 | |
| regulation of system process | GO:0044057 | 200 | 0.224 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.216 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.214 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.213 | |
| heart process | GO:0003015 | 94 | 0.211 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.210 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.207 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.204 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.204 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.203 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.201 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.196 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.196 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.189 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.186 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.183 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.182 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.182 | |
| myosin filament assembly | GO:0031034 | 2 | 0.180 | |
| cell communication involved in cardiac conduction | GO:0086065 | 9 | 0.179 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.177 | |
| muscle filament sliding | GO:0030049 | 1 | 0.174 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.174 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 2 | 0.172 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.170 | |
| neuromuscular process | GO:0050905 | 99 | 0.165 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.163 | |
| positive regulation of transmembrane transport | GO:0034764 | 29 | 0.162 | |
| potassium ion transport | GO:0006813 | 52 | 0.159 | |
| maintenance of location | GO:0051235 | 89 | 0.159 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.158 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.157 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.156 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.156 | |
| transition between fast and slow fiber | GO:0014883 | 9 | 0.155 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.154 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.151 | |
| cardiac chamber development | GO:0003205 | 108 | 0.150 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.150 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.149 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.149 | |
| myofibril assembly | GO:0030239 | 34 | 0.148 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.147 | |
| actin myosin filament sliding | GO:0033275 | 1 | 0.145 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.145 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.144 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.142 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.140 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.139 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.139 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.134 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.132 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.132 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.131 | |
| positive regulation of ryanodine sensitive calcium release channel activity | GO:0060316 | 1 | 0.131 | |
| response to inorganic substance | GO:0010035 | 96 | 0.130 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.130 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.129 | |
| organelle fission | GO:0048285 | 170 | 0.126 | |
| response to oxygen levels | GO:0070482 | 62 | 0.125 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.125 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.124 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.123 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.123 | |
| cation homeostasis | GO:0055080 | 212 | 0.123 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.122 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.122 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.122 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.121 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.120 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.119 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.119 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.118 | |
| positive regulation of ion transmembrane transport | GO:0034767 | 24 | 0.118 | |
| regulation of ion transport | GO:0043269 | 215 | 0.117 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.115 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.113 | |
| lung pattern specification process | GO:0060432 | 1 | 0.112 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.111 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.108 | |
| membrane depolarization during sa node cell action potential | GO:0086046 | 2 | 0.107 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.106 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.106 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.105 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.104 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.104 | |
| actin filament organization | GO:0007015 | 113 | 0.103 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.102 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.101 | |
| negative regulation of potassium ion transmembrane transporter activity | GO:1901017 | 3 | 0.101 | |
| response to metal ion | GO:0010038 | 47 | 0.100 | |
| positive regulation of ion transmembrane transporter activity | GO:0032414 | 15 | 0.100 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.099 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.098 | |
| calcium mediated signaling using intracellular calcium source | GO:0035584 | 3 | 0.098 | |
| positive regulation of calcium ion transmembrane transporter activity | GO:1901021 | 8 | 0.097 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.097 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.096 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.095 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.095 | |
| bone development | GO:0060348 | 120 | 0.095 | |
| regulation of relaxation of muscle | GO:1901077 | 8 | 0.094 | |
| relaxation of muscle | GO:0090075 | 18 | 0.094 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.094 | |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.093 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.091 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.090 | |
| cardiac muscle cell action potential | GO:0086001 | 11 | 0.087 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.087 | |
| cardiac cell development | GO:0055006 | 41 | 0.087 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.086 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.085 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.084 | |
| regulation of cation channel activity | GO:2001257 | 22 | 0.082 | |
| cardiac conduction | GO:0061337 | 17 | 0.082 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.081 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.081 | |
| regulation of potassium ion transmembrane transporter activity | GO:1901016 | 7 | 0.078 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.077 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.077 | |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.075 | Mouse |
| regulation of atpase activity | GO:0043462 | 9 | 0.075 | |
| feeding behavior | GO:0007631 | 62 | 0.075 | |
| myotube differentiation | GO:0014902 | 105 | 0.075 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.074 | |
| locomotory behavior | GO:0007626 | 195 | 0.074 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.073 | |
| response to hypoxia | GO:0001666 | 58 | 0.072 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.072 | |
| regulation of skeletal muscle adaptation | GO:0014733 | 12 | 0.069 | |
| male genitalia morphogenesis | GO:0048808 | 4 | 0.069 | |
| skeletal muscle myosin thick filament assembly | GO:0030241 | 1 | 0.068 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.068 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.068 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.067 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.065 | |
| eating behavior | GO:0042755 | 15 | 0.065 | |
| neuronal action potential | GO:0019228 | 54 | 0.064 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.064 | |
| organic anion transport | GO:0015711 | 137 | 0.063 | |
| anion transport | GO:0006820 | 177 | 0.063 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.063 | |
| cardiac muscle cell action potential involved in contraction | GO:0086002 | 6 | 0.063 | |
| regulation of high voltage gated calcium channel activity | GO:1901841 | 2 | 0.063 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.062 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.061 | |
| positive regulation of striated muscle contraction | GO:0045989 | 3 | 0.060 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.060 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.059 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.058 | |
| regulation of cardiac muscle cell contraction | GO:0086004 | 11 | 0.058 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.056 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.056 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.056 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.055 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.055 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.055 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.054 | |
| cellular homeostasis | GO:0019725 | 240 | 0.053 | |
| regulation of sarcomere organization | GO:0060297 | 4 | 0.053 | |
| positive regulation of high voltage gated calcium channel activity | GO:1901843 | 1 | 0.053 | |
| regulation of potassium ion transmembrane transport | GO:1901379 | 11 | 0.053 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.052 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.052 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.052 | |
| regulation of heart rate by chemical signal | GO:0003062 | 4 | 0.052 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.051 | |
| positive regulation of potassium ion transmembrane transport | GO:1901381 | 3 | 0.051 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.051 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.050 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.050 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.050 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.050 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.050 | |
| action potential | GO:0001508 | 78 | 0.049 | |
| amine metabolic process | GO:0009308 | 45 | 0.049 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.049 | |
| positive regulation of atp catabolic process | GO:1903291 | 3 | 0.048 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.048 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.048 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.047 | |
| vascular smooth muscle contraction | GO:0014829 | 5 | 0.047 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.047 | |
| positive regulation of white fat cell proliferation | GO:0070352 | 1 | 0.047 | |
| regulation of resting membrane potential | GO:0060075 | 3 | 0.046 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.046 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.046 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.045 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.044 | |
| protein localization to membrane | GO:0072657 | 108 | 0.043 | |
| protein localization to cell junction | GO:1902414 | 3 | 0.043 | |
| female genitalia morphogenesis | GO:0048807 | 3 | 0.042 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.042 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.042 | |
| male anatomical structure morphogenesis | GO:0090598 | 4 | 0.042 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.042 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.041 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.041 | |
| mitochondrion organization | GO:0007005 | 134 | 0.041 | |
| regulation of ryanodine sensitive calcium release channel activity | GO:0060314 | 10 | 0.041 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.040 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.040 | |
| adrenergic receptor signaling pathway | GO:0071875 | 13 | 0.040 | |
| regulation of calcium transporting atpase activity | GO:1901894 | 2 | 0.040 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.040 | |
| organelle localization | GO:0051640 | 179 | 0.039 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.039 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.039 | |
| protein oligomerization | GO:0051259 | 67 | 0.039 | |
| directional locomotion | GO:0033058 | 3 | 0.039 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.038 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.038 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.038 | |
| positive regulation of muscle contraction | GO:0045933 | 10 | 0.038 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.038 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.038 | |
| regulation of membrane depolarization | GO:0003254 | 11 | 0.038 | |
| cell cell signaling involved in cardiac conduction | GO:0086019 | 6 | 0.037 | |
| lung proximal distal axis specification | GO:0061115 | 1 | 0.037 | |
| cardiac muscle hypertrophy | GO:0003300 | 23 | 0.036 | |
| positive regulation of heart contraction | GO:0045823 | 14 | 0.036 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.036 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.035 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.035 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.034 | |
| ear development | GO:0043583 | 200 | 0.034 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.034 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.034 | |
| response to nutrient levels | GO:0031667 | 109 | 0.033 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.032 | |
| ossification involved in bone maturation | GO:0043931 | 12 | 0.032 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.032 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.032 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.032 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.031 | |
| camera type eye development | GO:0043010 | 266 | 0.031 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.031 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.031 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.031 | |
| semicircular canal formation | GO:0060876 | 1 | 0.031 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.031 | |
| regulation of heart rate | GO:0002027 | 36 | 0.031 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.031 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.030 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.030 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.030 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.030 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.030 | |
| lipid storage | GO:0019915 | 36 | 0.029 | |
| regulation of potassium ion transport | GO:0043266 | 16 | 0.029 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.029 | |
| bronchiole development | GO:0060435 | 3 | 0.029 | |
| embryonic genitalia morphogenesis | GO:0030538 | 4 | 0.029 | |
| renal sodium excretion | GO:0035812 | 3 | 0.029 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.029 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.029 | |
| vasoconstriction | GO:0042310 | 27 | 0.029 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.029 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.029 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.029 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.029 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.028 | |
| organ growth | GO:0035265 | 117 | 0.028 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.028 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.028 | |
| positive regulation of calcium transporting atpase activity | GO:1901896 | 1 | 0.028 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.028 | |
| lipid localization | GO:0010876 | 126 | 0.028 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.028 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.028 | |
| harderian gland development | GO:0070384 | 2 | 0.028 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.028 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.028 | |
| detection of stimulus | GO:0051606 | 84 | 0.028 | |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 3 | 0.027 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.027 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.027 | |
| stem cell development | GO:0048864 | 219 | 0.027 | |
| semicircular canal fusion | GO:0060879 | 1 | 0.027 | |
| positive regulation of blood circulation | GO:1903524 | 22 | 0.027 | |
| protein catabolic process | GO:0030163 | 221 | 0.027 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.027 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.027 | |
| neuron recognition | GO:0008038 | 25 | 0.027 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.027 | |
| amino acid transport | GO:0006865 | 61 | 0.027 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.027 | |
| positive regulation of transporter activity | GO:0032411 | 17 | 0.026 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.026 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.026 | |
| bone maturation | GO:0070977 | 13 | 0.026 | |
| skin development | GO:0043588 | 220 | 0.026 | |
| regulation of g protein activated inward rectifier potassium channel activity | GO:1900128 | 1 | 0.026 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.026 | |
| tissue homeostasis | GO:0001894 | 115 | 0.026 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.025 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.025 | |
| response to pain | GO:0048265 | 26 | 0.025 | |
| defecation | GO:0030421 | 1 | 0.025 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.025 | |
| t cell activation | GO:0042110 | 289 | 0.025 | |
| cell recognition | GO:0008037 | 83 | 0.025 | |
| positive regulation of heart rate | GO:0010460 | 10 | 0.025 | |
| regulation of actin filament based movement | GO:1903115 | 12 | 0.024 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.024 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.024 | |
| ossification | GO:0001503 | 216 | 0.024 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.024 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.024 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.024 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.024 | |
| protein homooligomerization | GO:0051260 | 43 | 0.024 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.024 | |
| angiogenesis | GO:0001525 | 201 | 0.023 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.023 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.023 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.023 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.023 | |
| membrane depolarization | GO:0051899 | 64 | 0.023 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.023 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.023 | |
| response to osmotic stress | GO:0006970 | 21 | 0.023 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.023 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.023 | |
| endocytosis | GO:0006897 | 168 | 0.023 | |
| nuclear division | GO:0000280 | 158 | 0.022 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.022 | |
| stem cell differentiation | GO:0048863 | 268 | 0.022 | |
| tubulin complex biogenesis | GO:0072668 | 2 | 0.022 | |
| protein ubiquitination | GO:0016567 | 171 | 0.022 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.022 | |
| protein polymerization | GO:0051258 | 57 | 0.022 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.022 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.022 | |
| endocrine system development | GO:0035270 | 98 | 0.022 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.021 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.021 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.021 | |
| adult behavior | GO:0030534 | 135 | 0.021 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.021 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.021 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.021 | |
| regulation of intestinal epithelial structure maintenance | GO:0060730 | 1 | 0.021 | |
| urogenital system development | GO:0001655 | 261 | 0.021 | |
| hormone metabolic process | GO:0042445 | 86 | 0.021 | |
| cell division | GO:0051301 | 120 | 0.021 | |
| regulation of pinocytosis | GO:0048548 | 1 | 0.021 | |
| regulation of tube size | GO:0035150 | 57 | 0.021 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.021 | |
| regulation of chloride transport | GO:2001225 | 2 | 0.020 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.020 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.020 | |
| multi organism behavior | GO:0051705 | 62 | 0.020 | |
| microtubule based process | GO:0007017 | 236 | 0.020 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.020 | |
| developmental maturation | GO:0021700 | 193 | 0.020 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.020 | |
| regulation of binding | GO:0051098 | 111 | 0.020 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.020 | |
| transition metal ion transport | GO:0000041 | 38 | 0.020 | |
| sensory perception | GO:0007600 | 245 | 0.020 | |
| protein maturation | GO:0051604 | 176 | 0.019 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.019 | |
| foramen ovale closure | GO:0035922 | 1 | 0.019 | |
| type b pancreatic cell apoptotic process | GO:0097050 | 6 | 0.019 | |
| immune effector process | GO:0002252 | 321 | 0.019 | |
| sclerotome development | GO:0061056 | 4 | 0.019 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.019 | |
| response to alkaloid | GO:0043279 | 34 | 0.019 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.019 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.019 | |
| fat cell proliferation | GO:0070341 | 4 | 0.019 | |
| deltoid tuberosity development | GO:0035993 | 3 | 0.019 | |
| cell growth | GO:0016049 | 130 | 0.019 | |
| positive regulation of renal sodium excretion | GO:0035815 | 2 | 0.019 | |
| positive regulation of cation channel activity | GO:2001259 | 8 | 0.019 | |
| response to inactivity | GO:0014854 | 4 | 0.019 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.018 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.018 | |
| tubulin complex assembly | GO:0007021 | 2 | 0.018 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.018 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.018 | |
| regulation of protein localization | GO:0032880 | 231 | 0.018 | |
| synaptic transmission | GO:0007268 | 329 | 0.018 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.018 | |
| ear morphogenesis | GO:0042471 | 118 | 0.018 | |
| heart trabecula formation | GO:0060347 | 14 | 0.018 | |
| acetate ester transport | GO:1901374 | 2 | 0.018 | |
| white fat cell proliferation | GO:0070343 | 2 | 0.017 | |
| organ maturation | GO:0048799 | 17 | 0.017 | |
| establishment or maintenance of neuroblast polarity | GO:0045196 | 1 | 0.017 | |
| negative regulation of potassium ion transmembrane transport | GO:1901380 | 4 | 0.017 | |
| protein localization to organelle | GO:0033365 | 185 | 0.017 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.017 | |
| axon ensheathment | GO:0008366 | 76 | 0.017 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.017 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.017 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.017 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.017 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.017 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.017 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.017 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.017 | |
| cellular response to lipid | GO:0071396 | 145 | 0.017 | |
| forebrain development | GO:0030900 | 302 | 0.016 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.016 | |
| l glutamate uptake involved in synaptic transmission | GO:0051935 | 3 | 0.016 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.016 | |
